| Primary |
| Drug Use For Unknown Indication |
38.1% |
| Endotracheal Intubation |
14.4% |
| Intravenous Catheter Management |
5.6% |
| Stress Echocardiogram |
5.6% |
| Sedation |
5.0% |
| Bradycardia |
3.8% |
| Cardiac Arrest |
3.8% |
| Ophthalmological Examination |
3.1% |
| Cardiac Stress Test |
2.5% |
| Palliative Care |
2.5% |
| Preoperative Care |
2.5% |
| Anaesthesia |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Strabismus |
1.9% |
| Acute Coronary Syndrome |
1.3% |
| Atrioventricular Block Second Degree |
1.3% |
| Diagnostic Procedure |
1.3% |
| Drooling |
1.3% |
| Gastrointestinal Carcinoma |
1.3% |
| Heart Rate Decreased |
1.3% |
|
| Toxicity To Various Agents |
9.4% |
| Medication Error |
7.5% |
| Tachycardia |
7.5% |
| Ventricular Tachycardia |
7.5% |
| Haemorrhage |
5.7% |
| Product Quality Issue |
5.7% |
| Vomiting |
5.7% |
| Wrong Drug Administered |
5.7% |
| Bradycardia |
3.8% |
| Bronchospasm |
3.8% |
| Device Breakage |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Drug Ineffective |
3.8% |
| Hallucination |
3.8% |
| Hypertension |
3.8% |
| No Adverse Event |
3.8% |
| Oxygen Saturation Decreased |
3.8% |
| Skin Laceration |
3.8% |
| Splenic Artery Aneurysm |
3.8% |
| Stress Cardiomyopathy |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
43.1% |
| Drug Use For Unknown Indication |
8.2% |
| Induction Of Anaesthesia |
5.1% |
| Premedication |
4.9% |
| Infection |
3.6% |
| Constipation |
3.5% |
| Sedation |
3.5% |
| Anaesthesia |
3.4% |
| Pyrexia |
3.4% |
| Hypertension |
3.0% |
| Ill-defined Disorder |
2.8% |
| Maintenance Of Anaesthesia |
2.7% |
| Anaesthesia Procedure |
2.0% |
| Muscle Relaxant Therapy |
2.0% |
| Analgesia |
1.6% |
| Diuretic Therapy |
1.6% |
| Antibiotic Therapy |
1.5% |
| General Anaesthesia |
1.4% |
| Ulcer |
1.4% |
| Anaesthetic Premedication |
1.3% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
24.8% |
| Toxic Epidermal Necrolysis |
11.6% |
| Disseminated Intravascular Coagulation |
7.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
5.8% |
| Injection Site Ulcer |
5.0% |
| Nausea |
5.0% |
| Proteinuria |
4.1% |
| Rash |
4.1% |
| Syncope |
4.1% |
| Inappropriate Antidiuretic Hormone Secretion |
3.3% |
| Muscular Weakness |
3.3% |
| Urticaria |
3.3% |
| Hypertension |
2.5% |
| Lip Oedema |
2.5% |
| Lymphocyte Stimulation Test Positive |
2.5% |
| Oxygen Saturation Decreased |
2.5% |
| Renal Failure Acute |
2.5% |
| Tachycardia |
2.5% |
| Anaphylactic Shock |
1.7% |
| Medication Error |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Drug Use For Unknown Indication |
13.0% |
| Prophylaxis |
6.7% |
| Induction Of Anaesthesia |
5.3% |
| Sedation |
5.2% |
| Fluid Replacement |
4.3% |
| Maintenance Of Anaesthesia |
4.0% |
| Infection |
3.3% |
| Premedication |
3.3% |
| Ureteral Stent Insertion |
3.1% |
| Ureteral Stent Removal |
3.1% |
| Anaesthesia |
3.0% |
| General Anaesthesia |
3.0% |
| Hypertension |
2.8% |
| Infection Prophylaxis |
2.5% |
| Anaesthesia Procedure |
2.4% |
| Diuretic Therapy |
1.9% |
| Anaesthetic Premedication |
1.8% |
| Pyrexia |
1.7% |
| Analgesic Therapy |
1.7% |
|
| Respiratory Failure |
11.1% |
| Rhabdomyolysis |
8.8% |
| Anaphylactic Shock |
7.6% |
| Vomiting |
6.4% |
| Ventricular Tachycardia |
5.8% |
| Ventricular Extrasystoles |
5.3% |
| Pulmonary Embolism |
4.7% |
| Toxic Epidermal Necrolysis |
4.7% |
| Ventricular Fibrillation |
4.7% |
| Ileus Paralytic |
4.1% |
| Multi-organ Failure |
4.1% |
| Paraesthesia |
4.1% |
| Tachycardia |
4.1% |
| Hypovolaemia |
3.5% |
| Pyrexia |
3.5% |
| Shock |
3.5% |
| Supraventricular Tachycardia |
3.5% |
| Urinary Tract Infection |
3.5% |
| Urine Output Increased |
3.5% |
| Venous Thrombosis Limb |
3.5% |
|
| Interacting |
| Amyotrophic Lateral Sclerosis |
25.0% |
| Increased Salivation |
25.0% |
| Muscle Cramps |
25.0% |
| Pain |
25.0% |
|
| Drug Interaction |
50.0% |
| General Physical Health Deterioration |
50.0% |
|
